Oxford Biosciences Cosmetic Product Experts Press Esc to close
Oxford Biosciences Cosmetic Product Experts Press Esc to close
Every product type carries its own regulatory weight. A sunscreen is tested differently from a lipstick; a fragrance is labelled differently from a face cream. These pages set out what applies where.
From rinse-off washes to leave-on lotions and deodorants: retained-exposure assessment, the deodorant-versus-antiperspirant classification, the preservative sensitisation rules, and the microplastics and antibacterial restrictions.
Learn more →Make-up is defined by its colorants and by where it is applied. The Annex IV positive list, lip-product ingestion exposure, eye-area microbiology, titanium dioxide, and the microplastics restriction reaching glitter and pigments.
Learn more →Fragrance carries its own regulatory weight: the expanded allergen labelling list under Regulation 2023/1545, restricted fragrance materials and IFRA standards, the alcohol base, and phototoxic citrus oils. Where the EU and UK now diverge on allergens.
Learn more →The compliance weight in hair care sits in oxidative dyes, strong sensitisers, aerosol propellants and formaldehyde-releasing treatments. The regulatory detail behind shampoos, conditioners, colourants and styling products.
Learn more →Nail systems carry the category's regulatory weight in methacrylate sensitisers, the recent prohibition of the photoinitiator TPO, and the toluene, formaldehyde and phthalate controls. HEMA and Di-HEMA are restricted to professional use.
Learn more →Toothpaste, mouthwash and whitening products are defined by oral exposure and by two strict controls: the fluoride limit and the hydrogen peroxide tooth-whitening regime. Plus the sharp line between a cosmetic and a medicine.
Learn more →The regulatory and safety considerations for leave-on facial skincare: high prolonged exposure and the margin of safety, the restricted actives (retinoids, skin-lightening agents, AHAs), preservation, and the line between cosmetic and medicinal claims.
Learn more →Sunscreens combine tightly controlled UV filters, a measured performance claim and an international cosmetic-versus-drug split. The Annex VI positive list, the homosalate, benzophenone-3 and octocrylene restrictions, nano filters, and SPF and UVA testing.
Learn more →Products for babies and young children are held to the most cautious assessment in cosmetics. Age-specific exposure and the margin of safety, the ingredient restrictions and warnings, stricter microbiology, and the limits on gentleness and hypoallergenic claims.
Learn more →CBD and hemp sit at the intersection of cosmetics law, narcotics control and medicines law. The Annex II prohibition on cannabis extracts, the permitted synthetic and seed-derived forms, the THC and controlled-cannabinoid limits, and why the source decides legality.
Learn more →Intimate care is defined by where it is applied. The Cosmetics Regulation covers the external mucous membranes, so these products are cosmetics, but mucosal application demands attention to pH, osmolality, irritation and microbiology, and the line with medicines is sharp.
Learn more →K-beauty is a market origin, not a product type. A Korean cosmetic, however compliant in Korea, is a new product when imported into the UK or EU and must meet the domestic regime in full, and Korea's ingredient lists do not match the EU's.
Learn more →Most men's grooming is assessed as conventional cosmetics, but a cluster of issues recurs: high-alcohol aftershaves on freshly shaved skin, the deodorant-versus-antiperspirant split, and shaving and hair-regrowth claims that edge into the medicines regime.
Learn more →Natural and organic are among the most used and least defined cosmetic claims. With no legal definition, compliance rests on the claims rules, the voluntary standards (ISO 16128, COSMOS, NATRUE), the preservation challenge, and the fact that natural does not mean safe.
Learn more →Professional-use-only is a genuine regulatory status, not marketing. It permits certain ingredients and higher concentrations barred from consumer products, changes the exposure and worker-safety picture, and carries a real diversion risk if professional products reach consumers.
Learn more →Vegan and cruelty-free are marketing positions, not legal categories. The substance is in the EU and UK animal-testing ban, the China market question, the REACH testing tension, and how the claims are policed under the Common Criteria.
Learn more →How UK and EU cosmetic compliance diverged after Brexit: dual Responsible Persons, SCPN and CPNP notification, market-specific labelling, the diverging annexes, and the Northern Ireland position under the Windsor Framework.
Learn more →Placing cosmetics on the EU market under Regulation (EC) No 1223/2009: the Annex I CPSR, an EU-established Responsible Person, CPNP notification, the claims rules, and the Omnibus annex updates. Cosmetics are not CE-marked.
Learn more →Taking one product into many markets without rebuilding the dossier each time. We hold a master evidence base and adapt it to each jurisdiction's requirements, including Certificates of Free Sale, apostille and legalisation, and sworn translation.
Learn more →Bringing a new or little-used ingredient to market: the toxicological dossier the safety assessment needs under the SCCS Notes of Guidance, nanomaterial and CMR rules, and the new-ingredient registration regimes in markets such as China.
Learn more →Determining whether a product is a cosmetic, a medicine or a medical device, and what changes if it crosses the line. The classification turns on claims and function, and it differs sharply between the EU, UK and US.
Learn more →How EU and UK REACH chemicals law applies to cosmetic ingredients alongside the Cosmetics Regulation: registration thresholds, the interface with cosmetic safety assessment, the diverging UK REACH deadlines, and supply-chain duties.
Learn more →Placing cosmetics on the Great Britain market: the assimilated UK Cosmetics Regulation, OPSS enforcement, a GB-based Responsible Person, the CPSR and PIF, SCPN notification, and the divergence from the EU under SI 2026/23. Cosmetics are not UKCA-marked.
Learn more →Regulatory due diligence for buying or investing in a cosmetic brand: a product-by-product audit of CPSRs, Responsible Persons, PIFs, notifications, claims and ingredient exposure, delivered as a report the deal can be priced against.
Learn more →Regulatory support for contract manufacturers and the brands that use them: cosmetic GMP under ISO 22716, the split of duties between manufacturer and Responsible Person, per-formula CPSRs and PIF compilation.
Learn more →Selling cosmetics online changes who is responsible and where. We handle Responsible Person designation by market, marketplace documentation, online claims and the importer duties that distance selling can trigger.
Learn more →Portfolio-scale regulatory compliance for established brands and groups: a named assessor, framework engagement, multi-market coordination, regulatory-change monitoring and agreed service levels across dozens or hundreds of products.
Learn more →Selling a manufacturer's formula under your own brand does not transfer the regulatory responsibility to you. We provide the CPSR, Responsible Person, labelling and claims work a private-label brand still needs in its own name.
Learn more →A retailer or distributor that stocks cosmetics it did not make still carries legal duties for what it sells. We provide distributor due-diligence, range and label audits, supplier-documentation checks and own-brand compliance.
Learn more →Everything an emerging or artisan brand needs to take its first cosmetic from formula to legally on sale: a CPSR, a Responsible Person, notification and a compliant label, assembled as one coordinated piece of work.
Learn more →A beauty box curator is selling cosmetics even when it made none of them. We cover the Responsible Person, importer and labelling duties that arise when products are sourced, decanted or repackaged into a subscription box.
Learn more →